DARE BIOSCIENCE, INC.

Profile

Company Names

DARE BIOSCIENCE, INC.
CERULEAN PHARMA INC.

Addresses

3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA 92122

11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA, CA 92037

35 GATEHOUSE DRIVE, WALTHAM, MA 02451

840 MEMORIAL DRIVE, 5TH FLOOR, CAMBRIDGE, MA 02139

161 FIRST STREET, CAMBRIDGE, MA 02142

Phone Numbers

858-926-7655
858-769-9145
781-996-4300
617-551-9600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$86,969,972.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2024-10-21 
$0.00 
$15,000,000.00 
$15,000,000.00 
Equity 
10
2023-12-21 
$1,733,500.00 
$4,160,400.00 
$2,426,900.00 
 
9
2019-11-20 
$3,544,992.00 
$3,544,992.00 
$0.00 
Equity 
8
2017-07-19 
$20,691,388.00 
$20,691,388.00 
$0.00 
Equity 
7
2016-10-04 
$1.00 
$1.00 
$0.00 
 
6
2012-11-30 
$13,000,000.00 
$13,000,000.00 
$0.00 
Equity 
5
2011-12-02 
$15,000,098.00 
$15,000,098.00 
$0.00 
Equity 
4
2010-11-12 
$16,499,994.00 
$23,999,989.00 
$7,499,995.00 
Equity 
3
2010-09-29 
$1,499,999.00 
$1,499,999.00 
$0.00 
Debt 
2
2010-05-26 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
1
2009-07-13 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STUART 
A. 
ARBUCKLE 
DIRECTOR
CHERYL 
 
BLANCHARD 
DIRECTOR
CHERYL 
R. 
BLANCHARD 
DIRECTOR
ALEJANDRA 
V. 
CARVAJAL 
EXECUTIVE OFFICER
ALAN 
L. 
CRANE 
DIRECTOR
DAVID 
P. 
DEMAGISTRIS 
EXECUTIVE OFFICER
OLIVER 
 
FETZER 
EXECUTIVE OFFICER, DIRECTOR
PAUL 
A. 
FRIEDMAN 
DIRECTOR
EDWARD 
 
GARMEY 
EXECUTIVE OFFICER
ALEXANDRA 
 
GLUCKSMANN 
EXECUTIVE OFFICER
JESSICA 
 
GROSSMAN 
DIRECTOR
JESSICA 
D. 
GROSSMAN 
DIRECTOR
CHRISTOPHER 
D.T. 
GUIFFRE 
EXECUTIVE OFFICER, DIRECTOR
STEVEN 
E. 
HALL 
DIRECTOR
MARDEE 
 
HARING-LAYTON 
EXECUTIVE OFFICER
ROGER 
L. 
HAWLEY 
DIRECTOR
SABRINA 
MARTUCCI 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
SUSAN 
L. 
KELLEY 
DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
GREGORY 
W. 
MATZ 
DIRECTOR
WILLIAM 
T. 
MCKEE 
DIRECTOR
SOPHIA 
N. 
ONONYE-ONYIA 
DIRECTOR
DAVID 
R. 
PARKINSON 
DIRECTOR
WILLIAM 
H. 
RASTETTER 
DIRECTOR
KAREN 
 
ROBERTS 
EXECUTIVE OFFICER
RAM 
 
SASISEKHARAN 
DIRECTOR
ADRIAN 
 
SENDEROWICZ 
EXECUTIVE OFFICER
JEAN 
 
SILVERI 
EXECUTIVE OFFICER
ROBIN 
J. 
STEELE 
DIRECTOR
DAVID 
R. 
WALT 
DIRECTOR
LISA 
 
WALTERS-HOFFERT 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-10-21 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-12-21 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-11-20 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-11-20 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-07-19 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-10-04 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-12 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-09-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-26 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#